Improving cefazolin exposure in critically ill children using a population pharmacokinetic model.
Rivaud C, Oualha M, Salvador E, Bille E, Callot D, Béranger A, Bournaud LF, Rouillon S, Toubiana J, Benaboud S, Renolleau S, Treluyer JM, Hirt D, de Cacqueray N.
Rivaud C, et al.
Br J Clin Pharmacol. 2024 Aug 29. doi: 10.1111/bcp.16224. Online ahead of print.
Br J Clin Pharmacol. 2024.
PMID: 39209527